ADA Scientific Sessions 2026 Abstract

Trends in Utilization of Glucose Lowering Medications among Patients with Type 1 Diabetes in the United States

By Janinne Ortega Montiel, Hanseul Cho, Sara Cromer, Elisabetta Patorno

Study in peoplePopulations

The paper

Janinne Ortega Montiel, Hanseul Cho, Sara Cromer, Elisabetta Patorno

Boston

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 2375-P

doi.org/10.2337/db26-2375-p

Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes